<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0745091" disease_type="Disease or Syndrome" abbrv="">Hypereosinophilia</z:e> is a rare presenting sign of <z:hpo ids='HP_0011009'>acute</z:hpo> lymphocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>A 29-year-old male was diagnosed with <z:e sem="disease" ids="C0206141" disease_type="Disease or Syndrome" abbrv="">idiopathic hypereosinophilic syndrome</z:e> with respiratory symptoms </plain></SENT>
<SENT sid="2" pm="."><plain>Although his peripheral blood <z:hpo ids='HP_0001880'>eosinophilia</z:hpo> decreased in response to treatment with <z:chebi fb="0" ids="31690">imatinib mesylate</z:chebi>, a follow-up bone marrow showed a diffuse infiltrate of myeloperoxidase-negative blasts </plain></SENT>
<SENT sid="3" pm="."><plain>He was subsequently diagnosed with CD10 positive precursor B lymphoblastic <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>This case underscores the importance of follow-up bone marrow examination in patients who demonstrate <z:chebi fb="0" ids="31690">imatinib mesylate</z:chebi>-responsive <z:hpo ids='HP_0001880'>eosinophilia</z:hpo> </plain></SENT>
</text></document>